Bezos' $10M Donation to Hutch to be Used for Immunotherapy Program | GenomeWeb

NEW YORK (GenomeWeb News) – The Fred Hutchinson Cancer Research Center will use the $10 million pledged recently by the family of Amazon.com founder Jeff Bezos to jumpstart a new program devoted to expanding the practice of immunotherapy beyond blood borne cancers, to breast, ovarian, and prostate cancers among other forms of the disease.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genes involved in histone deacetylation in Arabidopsis, effects of pathogenic presenilin-1 mutations, and more.

After a study finds DNA from antibiotic-resistant bacteria in Beijing smog, residents there worry, according to the New York Times.

Canada begins its search for a chief government science advisor, Nature News reports.

A company is using facial recognition tools to identify genetic disorders from pictures, Technology Review reports.